VIJAY NAMBI to Inflammation
This is a "connection" page, showing publications VIJAY NAMBI has written about Inflammation.
Connection Strength
0.796
-
Inflammation and cardiovascular risk. Vijay Nambi speaks to Christine Forder, commissioning editor. Future Cardiol. 2009 Mar; 5(2):121-3.
Score: 0.194
-
Novel markers of inflammation in atherosclerosis. Curr Atheroscler Rep. 2008 Apr; 10(2):164-70.
Score: 0.182
-
The role of lipoprotein-associated phospholipase A2 as a marker for atherosclerosis. Curr Atheroscler Rep. 2007 Aug; 9(2):97-103.
Score: 0.174
-
Markers of inflammation and their clinical significance. Atheroscler Suppl. 2005 May; 6(2):21-9.
Score: 0.149
-
Lipoprotein-associated phospholipase A2 and high-sensitivity C-reactive protein improve the stratification of ischemic stroke risk in the Atherosclerosis Risk in Communities (ARIC) study. Stroke. 2009 Feb; 40(2):376-81.
Score: 0.048
-
Obesity, Galectin-3, and Incident Heart Failure: The ARIC Study. J Am Heart Assoc. 2022 05 03; 11(9):e023238.
Score: 0.030
-
Association between lipoprotein associated phospholipase A2 mass and subclinical coronary and carotid atherosclerosis in Retired National Football League players. Atherosclerosis. 2014 Oct; 236(2):251-6.
Score: 0.018